These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17047085)

  • 1. Comparative proteomic profiles of meningioma subtypes.
    Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
    Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.
    Wibom C; Mörén L; Aarhus M; Knappskog PM; Lund-Johansen M; Antti H; Bergenheim AT
    J Neurooncol; 2009 Sep; 94(3):321-31. PubMed ID: 19350207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of meningiomas.
    Cui GQ; Jiao AH; Xiu CM; Wang YB; Sun P; Zhang LM; Li XG
    Acta Neurol Belg; 2014 Sep; 114(3):187-94. PubMed ID: 24085542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin predicts the behaviour of atypical meningioma.
    Lin CK; Tsai WC; Lin YC; Hueng DY
    Histopathology; 2012 Jan; 60(2):320-5. PubMed ID: 22211290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
    Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
    J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
    Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
    Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
    Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
    Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
    Mahzouni P; Movahedipour M
    Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological classification and molecular genetics of meningiomas.
    Riemenschneider MJ; Perry A; Reifenberger G
    Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PS6K amplification characterizes a small subset of anaplastic meningiomas.
    Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A
    Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
    Myong NH; Chi JG
    J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation.
    Weisberg S; Ashkenazi E; Israel Z; Attia M; Shoshan Y; Umansky F; Brodie C
    Am J Pathol; 2001 Oct; 159(4):1193-7. PubMed ID: 11583945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of meningioma grading: a 10-year retrospective audit.
    Willis J; Smith C; Ironside JW; Erridge S; Whittle IR; Everington D
    Neuropathol Appl Neurobiol; 2005 Apr; 31(2):141-9. PubMed ID: 15771707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
    Trinkaus M; Vranic A; Dolenc VV; Lah TT
    Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.